These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34671344)

  • 1. Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE.
    Deng L; Chen Y; Hu X; Zhou J; Zhang Y
    Front Immunol; 2021; 12():708463. PubMed ID: 34671344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia].
    Xia FF; Lu FA; Lv HM; Yang GA; Liu Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):266-272. PubMed ID: 33879896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report: The efficacy of pirfenidone in a Chinese patient with progressive systemic sclerosis-associated interstitial lung disease: A CARE-compliant article.
    Huang H; Feng RE; Li S; Xu K; Bi YL; Xu ZJ
    Medicine (Baltimore); 2016 Jul; 95(27):e4113. PubMed ID: 27399114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.
    Deneuville L; Mageau A; Debray MP; Sacre K; Costedoat-Chalumeau N; Hachulla E; Uzunhan Y; Le Tallec E; Cadranel J; Marchand Adam S; Montani D; Rémi-Jardin M; Reynaud-Gaubert M; Prevot G; Beltramo G; Crestani B; Cottin V; Borie R;
    Respirology; 2024 Aug; 29(8):713-721. PubMed ID: 38494831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy.
    Suzuki K; Tanaka H; Tsugawa K; Ito E
    Tohoku J Exp Med; 2006 Apr; 208(4):355-9. PubMed ID: 16565599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.
    Kobayashi I; Yamada M; Takahashi Y; Kawamura N; Okano M; Sakiyama Y; Kobayashi K
    Rheumatology (Oxford); 2003 Feb; 42(2):371-4. PubMed ID: 12595639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful therapy with cyclosporine in a case with interstitial pneumonitis associated with polymyositis].
    Soga T; Hagiwara E; Shirai A; Igarashi T; Ishigatsubo Y; Okubo T
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Apr; 19(2):157-62. PubMed ID: 8705693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
    Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
    J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
    Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
    Richter P; Cardoneanu A; Dima N; Bratoiu I; Rezus C; Burlui AM; Costin D; Macovei LA; Rezus E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
    Nawata M; Nagayasu A; Fujita Y; Nawata A; Saito K; Tanaka Y
    Lupus; 2020 Dec; 29(14):1955-1960. PubMed ID: 32914681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical experience of pirfenidone based on corticosteroids and immunosuppressant treatment for interstitial pneumonia with autoimmune features].
    Huang H; Sun YX; Li S; Shao C; Xu K; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Sep; 42(9):700-704. PubMed ID: 31484245
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical spectrum of children with interstitial pneumonia with autoimmune features.
    Ademhan Tural D; Emiralioglu N; Ozsezen B; Sunman B; Nayir Buyuksahin H; Guzelkas I; Oguz B; Bilginer Y; Orhan D; Yalcin E; Dogru D; Ozcelik U; Ozen S; Kiper N
    Respir Med; 2021 Oct; 187():106566. PubMed ID: 34416614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
    Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
    Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
    DeCoste C; Mateos-Corral D; Lang B
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):7. PubMed ID: 33407629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with tacrolimus in a case of lung-dominant connective tissue disease.
    Okamoto M; Fujimoto K; Nakamura M; Yoshida T; Idemoto A; Kitasato Y; Kawayama T; Fukuoka J; Ichiki M; Hoshino T
    Intern Med; 2013; 52(5):605-9. PubMed ID: 23448773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.